Company intelligence / Profile preview
Kelso Pharma
Kelso, Scotland, United Kingdomkelsopharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Kelso Pharma develops and commercializes innovative, value-added specialty medicines targeted at the European healthcare market. The company emphasizes providing meaningful benefits to patients while ensuring cost-effectiveness for healthcare systems. Specific clinical results or product data are not publicly detailed in the available sources.
- Modalities
- small moleculesbranded medicines
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Apposite Capital (healthcare impact investor)
Beyond the preview
Go deeper on Kelso Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kelso Pharma.